Alkermes plc

ALKSNASDAQHealthcare● Active

$42.45

$-0.35(-0.82%)

Market Cap$7.1B

P/E Ratio—

52W High$43.78

52W Low$25.17

Avg Volume2.4M

Open$42.77

Beta0.33

Free Cash Flow Financials Revenue

Alkermes plc (ALKS) Free Cash Flow & Analysis

Annual & trailing free cash flow, FCF margin, YoY change, valuation ratios, and peer context.

ALKS · free cash flow · updated Jun 8, 2026

Core FCF metrics

ALKS · FCF · TTM · margin & CAGR

Free cash flow was $480.3M for FY2025 (fiscal year ending 2025-12-31), up 18.4% year-over-year The FCF margin was 32.5%. Five-year CAGR stands at +63.9%.

FY2025 Free Cash Flow$480.3M▲ +18.4% YoY

Trailing 12M (TTM)$221.8Mtrailing 4 quarters sum

FCF Margin32.5%$480.3M ÷ revenue

3-Year CAGRN/AN/A — contains negative FCF

5-Year CAGR+63.9%FY2020 → FY2025

FormulaFCF = Operating Cash Flow − Capital ExpendituresTTM = trailing 4 quarters sumCAGR → N/A if either endpoint ≤ 0

Source: FMP /cash-flow-statement · SEC 10-K / 10-Q · USDUpdated: Jun 8, 2026

Annual free cash flow history

FCF ($B, upper) · YoY Growth % (lower)

Positive FCFNegative FCF

Free Cash Flow

YoY Growth %

Annual free cash flow data

ALKS · free cash flow history · annual / quarterly

Fiscal YearOperating CFCapExFree Cash FlowYoY ChangeFCF Margin

FY2025Latest$520.8M(40M)$480.3M▲ +18.4%32.5%

FY2024$439.1M(33M)$405.6M▲ +14.8%26.0%

FY2023$401.4M(48M)$353.3M▲ +2152.8%21.2%

FY2022$21.0M(38M)−$17.2M▼ 123.7%-1.6%

FY2021$101.7M(29M)$72.7M▲ +79.0%6.2%

FCF = Operating Cash Flow − Capital Expenditures · CapEx shown as (negative) · Source: SEC filings via FMP

FCF valuation metrics

ALKS · P/FCF · FCF yield · FCF per share

Alkermes plc (ALKS) trades at a FCF yield of 3.12% and a price-to-free-cash-flow ratio of 31.4x. FCF per share stands at $1.35, calculated using trailing twelve-month FCF divided by basic weighted-average shares outstanding.

FCF Yield (TTM)

3.12%

Free Cash Flow ÷ Market Cap

per FMP freeCashFlowYieldTTM definition

FCF per Share (TTM)

$1.35

TTM FCF ÷ Shares Outstanding

Price / FCF

x31.4

Share Price ÷ FCF per Share

EV / FCF (TTM)

x37.6

Enterprise Value basis

Source: FMP /key-metrics-ttm · /cash-flow-statement Q · /income-statementFY2025 · 2025-12-31

Cash flow statement summary

ALKS · cash flow statement · operating / investing / financing

For FY2025, Alkermes plc generated $520.8M in operating cash flow and spent 40M in capital expenditures, yielding $480.3M in free cash flow.

Operating Activities

+$520.8M

Cash from core business operations

2025-12-31

Investing Activities

+$295.5M

CapEx, acquisitions & investments

2025-12-31

Financing Activities

+$12.4M

Buybacks, dividends & debt

2025-12-31

FCF FormulaOperating CF ($520.8M) − |CapEx| (40M) = FCF ($480.3M)

For the complete Operating / Investing / Financing line-item breakdown:

View Full Cash Flow Statement →

Free cash flow vs peers (Healthcare)

ALKS vs peers · FCF

#CompanyFree Cash FlowYoYFCF MarginRelative

Alkermes plcYOU

ALKS

$480.3M+18.4%32.5%

UnitedHealth Group Incorporated

UNH

$16.07B-22.4%3.6%

82%

Eli Lilly and Company

LLY

$8.97B+2065.6%13.8%

46%

Healthcare · Sorted by FCF · FMP /cash-flow-statementFull FCF Rankings →

About Free Cash Flow & Methodology

Alkermes plc (ALKS) reported free cash flow of $480.3M for FY2025 (fiscal year ending 2025-12-31), up 18.4% year-over-year. The FCF margin was 32.5%.

Based on available data, Alkermes plc has maintained positive free cash flow for at least 7 fiscal year(s). FCF peaked at $480.3M in FY2025. The 5-year CAGR stands at +63.9%.

Alkermes plc's FCF yield is 3.12% and price-to-FCF ratio is 31.4x for FY2025, based on the latest available data.

Data sourced from FMP /cash-flow-statement · SEC 10-K / 10-Q · USD.

Q&A and summaries align with SEC 10-K/10-Q cash flow disclosures and FMP /cash-flow-statement where noted.

Revenue Financial statements Net income Earnings Forecast Price history Market cap Cash on hand P/E ratio

Frequently asked questions

ALKS free cash flow · 8 questions

Alkermes plc free cash flow was $480.3M for FY2025, up 18.4% year-over-year. On a trailing twelve-month (TTM) basis, free cash flow stands at $221.8M.

ALKS free cash flowALKS FCFALKS FCF 2025ALKS free cash flow TTM

▸ Source: FMP /cash-flow-statement · US GAAP · Alkermes plc · Alkermes plc SEC 10-K & 10-Q filings · US GAAP · Last updated: Jun 8, 2026